-
1
-
-
0033785491
-
Expression levels of gp130 in bone marrow stromal cells determine the magnitude of osteoclastogenic signals generated by IL-6-type cytokines
-
O'Brien CA, Lin SC, Bellido T, Manolagas SC, (2000) Expression levels of gp130 in bone marrow stromal cells determine the magnitude of osteoclastogenic signals generated by IL-6-type cytokines. Journal of cellular biochemistry 79: 532-541.
-
(2000)
Journal of Cellular Biochemistry
, vol.79
, pp. 532-541
-
-
O'Brien, C.A.1
Lin, S.C.2
Bellido, T.3
Manolagas, S.C.4
-
2
-
-
1542313900
-
IL-3 expression by myeloma cells increases both osteoclast formation and growth of myeloma cells
-
Lee JW, Chung HY, Ehrlich LA, Jelinek DF, Callander NS, et al. (2004) IL-3 expression by myeloma cells increases both osteoclast formation and growth of myeloma cells. Blood 103: 2308-2315.
-
(2004)
Blood
, vol.103
, pp. 2308-2315
-
-
Lee, J.W.1
Chung, H.Y.2
Ehrlich, L.A.3
Jelinek, D.F.4
Callander, N.S.5
-
3
-
-
0026443460
-
The critical role of interleukin-6, interleukin-1B and macrophage colony-stimulating factor in the pathogenesis of bone lesions in multiple myeloma
-
Bataille R, Chappard D, Klein B, (1992) The critical role of interleukin-6, interleukin-1B and macrophage colony-stimulating factor in the pathogenesis of bone lesions in multiple myeloma. International journal of clinical & laboratory research 21: 283-287.
-
(1992)
International Journal of Clinical & Laboratory Research
, vol.21
, pp. 283-287
-
-
Bataille, R.1
Chappard, D.2
Klein, B.3
-
4
-
-
28244452125
-
Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway
-
Bendre MS, Margulies AG, Walser B, Akel NS, Bhattacharrya S, et al. (2005) Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway. Cancer research 65: 11001-11009.
-
(2005)
Cancer Research
, vol.65
, pp. 11001-11009
-
-
Bendre, M.S.1
Margulies, A.G.2
Walser, B.3
Akel, N.S.4
Bhattacharrya, S.5
-
5
-
-
33846614551
-
CCL20 chemokine induces both osteoblast proliferation and osteoclast differentiation: Increased levels of CCL20 are expressed in subchondral bone tissue of rheumatoid arthritis patients
-
Lisignoli G, Piacentini A, Cristino S, Grassi F, Cavallo C, et al. (2007) CCL20 chemokine induces both osteoblast proliferation and osteoclast differentiation: Increased levels of CCL20 are expressed in subchondral bone tissue of rheumatoid arthritis patients. Journal of cellular physiology 210: 798-806.
-
(2007)
Journal of Cellular Physiology
, vol.210
, pp. 798-806
-
-
Lisignoli, G.1
Piacentini, A.2
Cristino, S.3
Grassi, F.4
Cavallo, C.5
-
6
-
-
0034305350
-
Levels of interleukin-1 beta, -8, and -10 and RANTES in gingival crevicular fluid and cell populations in adult periodontitis patients and the effect of periodontal treatment
-
Gamonal J, Acevedo A, Bascones A, Jorge O, Silva A, (2000) Levels of interleukin-1 beta,-8, and-10 and RANTES in gingival crevicular fluid and cell populations in adult periodontitis patients and the effect of periodontal treatment. Journal of periodontology 71: 1535-1545.
-
(2000)
Journal of Periodontology
, vol.71
, pp. 1535-1545
-
-
Gamonal, J.1
Acevedo, A.2
Bascones, A.3
Jorge, O.4
Silva, A.5
-
7
-
-
27644460267
-
Increase of CCL20 expression by human gingival fibroblasts upon stimulation with cytokines and bacterial endotoxin
-
Hosokawa Y, Hosokawa I, Ozaki K, Nakae H, Matsuo T, (2005) Increase of CCL20 expression by human gingival fibroblasts upon stimulation with cytokines and bacterial endotoxin. Clinical and experimental immunology 142: 285-291.
-
(2005)
Clinical and Experimental Immunology
, vol.142
, pp. 285-291
-
-
Hosokawa, Y.1
Hosokawa, I.2
Ozaki, K.3
Nakae, H.4
Matsuo, T.5
-
8
-
-
34250175854
-
CXC chemokine ligand 16 in periodontal diseases: expression in diseased tissues and production by cytokine-stimulated human gingival fibroblasts
-
Hosokawa Y, Hosokawa I, Ozaki K, Nakae H, Matsuo T, (2007) CXC chemokine ligand 16 in periodontal diseases: expression in diseased tissues and production by cytokine-stimulated human gingival fibroblasts. Clinical and experimental immunology 149: 146-154.
-
(2007)
Clinical and Experimental Immunology
, vol.149
, pp. 146-154
-
-
Hosokawa, Y.1
Hosokawa, I.2
Ozaki, K.3
Nakae, H.4
Matsuo, T.5
-
9
-
-
0342322717
-
Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma
-
Choi SJ, Cruz JC, Craig F, Chung H, Devlin RD, et al. (2000) Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma. Blood 96: 671-675.
-
(2000)
Blood
, vol.96
, pp. 671-675
-
-
Choi, S.J.1
Cruz, J.C.2
Craig, F.3
Chung, H.4
Devlin, R.D.5
-
10
-
-
0035383761
-
Macrophage inflammatory protein-1alpha is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor kappaB ligand
-
Han JH, Choi SJ, Kurihara N, Koide M, Oba Y, et al. (2001) Macrophage inflammatory protein-1alpha is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor kappaB ligand. Blood 97: 3349-3353.
-
(2001)
Blood
, vol.97
, pp. 3349-3353
-
-
Han, J.H.1
Choi, S.J.2
Kurihara, N.3
Koide, M.4
Oba, Y.5
-
11
-
-
0035664488
-
Antisense inhibition of macrophage inflammatory protein 1-alpha blocks bone destruction in a model of myeloma bone disease
-
Choi SJ, Oba Y, Gazitt Y, Alsina M, Cruz J, et al. (2001) Antisense inhibition of macrophage inflammatory protein 1-alpha blocks bone destruction in a model of myeloma bone disease. The Journal of clinical investigation 108: 1833-1841.
-
(2001)
The Journal of Clinical Investigation
, vol.108
, pp. 1833-1841
-
-
Choi, S.J.1
Oba, Y.2
Gazitt, Y.3
Alsina, M.4
Cruz, J.5
-
12
-
-
40449124249
-
Macrophage inflammatory protein-1 delta: a novel osteoclast stimulating factor secreted by renal cell carcinoma bone metastasis
-
Kominsky SL, Abdelmagid SM, Doucet M, Brady K, Weber KL, (2008) Macrophage inflammatory protein-1 delta: a novel osteoclast stimulating factor secreted by renal cell carcinoma bone metastasis. Cancer research 68: 1261-1266.
-
(2008)
Cancer Research
, vol.68
, pp. 1261-1266
-
-
Kominsky, S.L.1
Abdelmagid, S.M.2
Doucet, M.3
Brady, K.4
Weber, K.L.5
-
13
-
-
0346525140
-
U0126 and PD98059, specific inhibitors of MEK, accelerate differentiation of RAW264.7 cells into osteoclast-like cells
-
Hotokezaka H, Sakai E, Kanaoka K, Saito K, Matsuo K, et al. (2002) U0126 and PD98059, specific inhibitors of MEK, accelerate differentiation of RAW264.7 cells into osteoclast-like cells. The Journal of biological chemistry 277: 47366-47372.
-
(2002)
The Journal of Biological Chemistry
, vol.277
, pp. 47366-47372
-
-
Hotokezaka, H.1
Sakai, E.2
Kanaoka, K.3
Saito, K.4
Matsuo, K.5
-
14
-
-
0037113034
-
JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms
-
David JP, Sabapathy K, Hoffmann O, Idarraga MH, Wagner EF, (2002) JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and-independent mechanisms. Journal of cell science 115: 4317-4325.
-
(2002)
Journal of Cell Science
, vol.115
, pp. 4317-4325
-
-
David, J.P.1
Sabapathy, K.2
Hoffmann, O.3
Idarraga, M.H.4
Wagner, E.F.5
-
15
-
-
33750597150
-
PLCgamma2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2
-
Mao D, Epple H, Uthgenannt B, Novack DV, Faccio R, (2006) PLCgamma2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2. The Journal of clinical investigation 116: 2869-2879.
-
(2006)
The Journal of Clinical Investigation
, vol.116
, pp. 2869-2879
-
-
Mao, D.1
Epple, H.2
Uthgenannt, B.3
Novack, D.V.4
Faccio, R.5
-
16
-
-
0030715563
-
Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2
-
Iotsova V, Caamano J, Loy J, Yang Y, Lewin A, et al. (1997) Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. Nature medicine 3: 1285-1289.
-
(1997)
Nature Medicine
, vol.3
, pp. 1285-1289
-
-
Iotsova, V.1
Caamano, J.2
Loy, J.3
Yang, Y.4
Lewin, A.5
-
17
-
-
78650920066
-
Non-canonical NF-kappaB signaling pathway
-
Sun SC, (2011) Non-canonical NF-kappaB signaling pathway. Cell research 21: 71-85.
-
(2011)
Cell Research
, vol.21
, pp. 71-85
-
-
Sun, S.C.1
-
18
-
-
34547124586
-
NF-kappaB p50 and p52 regulate receptor activator of NF-kappaB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1
-
Yamashita T, Yao Z, Li F, Zhang Q, Badell IR, et al. (2007) NF-kappaB p50 and p52 regulate receptor activator of NF-kappaB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1. The Journal of biological chemistry 282: 18245-18253.
-
(2007)
The Journal of Biological Chemistry
, vol.282
, pp. 18245-18253
-
-
Yamashita, T.1
Yao, Z.2
Li, F.3
Zhang, Q.4
Badell, I.R.5
-
19
-
-
77953482256
-
Processing of the NF-kappa B2 precursor p100 to p52 is critical for RANKL-induced osteoclast differentiation
-
Maruyama T, Fukushima H, Nakao K, Shin M, Yasuda H, et al. (2010) Processing of the NF-kappa B2 precursor p100 to p52 is critical for RANKL-induced osteoclast differentiation. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research 25: 1058-1067.
-
(2010)
Journal of Bone and Mineral Research: The Official Journal of the American Society for Bone and Mineral Research
, vol.25
, pp. 1058-1067
-
-
Maruyama, T.1
Fukushima, H.2
Nakao, K.3
Shin, M.4
Yasuda, H.5
-
20
-
-
33947583822
-
Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems
-
Takayanagi H, (2007) Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nature reviews Immunology 7: 292-304.
-
(2007)
Nature Reviews Immunology
, vol.7
, pp. 292-304
-
-
Takayanagi, H.1
-
21
-
-
2942731511
-
Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos
-
Matsuo K, Galson DL, Zhao C, Peng L, Laplace C, et al. (2004) Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos. The Journal of biological chemistry 279: 26475-26480.
-
(2004)
The Journal of Biological Chemistry
, vol.279
, pp. 26475-26480
-
-
Matsuo, K.1
Galson, D.L.2
Zhao, C.3
Peng, L.4
Laplace, C.5
-
22
-
-
41649089360
-
RelB is the NF-kappaB subunit downstream of NIK responsible for osteoclast differentiation
-
Vaira S, Johnson T, Hirbe AC, Alhawagri M, Anwisye I, et al. (2008) RelB is the NF-kappaB subunit downstream of NIK responsible for osteoclast differentiation. Proceedings of the National Academy of Sciences of the United States of America 105: 3897-3902.
-
(2008)
Proceedings of the National Academy of Sciences of the United States of America
, vol.105
, pp. 3897-3902
-
-
Vaira, S.1
Johnson, T.2
Hirbe, A.C.3
Alhawagri, M.4
Anwisye, I.5
-
23
-
-
45749124735
-
RelA/p65 promotes osteoclast differentiation by blocking a RANKL-induced apoptotic JNK pathway in mice
-
Vaira S, Alhawagri M, Anwisye I, Kitaura H, Faccio R, et al. (2008) RelA/p65 promotes osteoclast differentiation by blocking a RANKL-induced apoptotic JNK pathway in mice. The Journal of clinical investigation 118: 2088-2097.
-
(2008)
The Journal of Clinical Investigation
, vol.118
, pp. 2088-2097
-
-
Vaira, S.1
Alhawagri, M.2
Anwisye, I.3
Kitaura, H.4
Faccio, R.5
-
24
-
-
33144463109
-
Chemokine and chemokine receptor expression in paired peripheral blood mononuclear cells and synovial tissue of patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis
-
Haringman JJ, Smeets TJ, Reinders-Blankert P, Tak PP, (2006) Chemokine and chemokine receptor expression in paired peripheral blood mononuclear cells and synovial tissue of patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis. Annals of the rheumatic diseases 65: 294-300.
-
(2006)
Annals of the Rheumatic Diseases
, vol.65
, pp. 294-300
-
-
Haringman, J.J.1
Smeets, T.J.2
Reinders-Blankert, P.3
Tak, P.P.4
-
25
-
-
18944402657
-
Proteolytic activation of alternative CCR1 ligands in inflammation
-
Berahovich RD, Miao Z, Wang Y, Premack B, Howard MC, et al. (2005) Proteolytic activation of alternative CCR1 ligands in inflammation. Journal of immunology 174: 7341-7351.
-
(2005)
Journal of Immunology
, vol.174
, pp. 7341-7351
-
-
Berahovich, R.D.1
Miao, Z.2
Wang, Y.3
Premack, B.4
Howard, M.C.5
-
27
-
-
0028928988
-
Use of an in vivo model to determine the effects of interleukin-1 on cells at different stages in the osteoclast lineage
-
Uy HL, Dallas M, Calland JW, Boyce BF, Mundy GR, et al. (1995) Use of an in vivo model to determine the effects of interleukin-1 on cells at different stages in the osteoclast lineage. Journal of bone and mineral research: the official journal of the American Society for Bone and Mineral Research 10: 295-301.
-
(1995)
Journal of Bone and Mineral Research: The Official Journal of the American Society for Bone and Mineral Research
, vol.10
, pp. 295-301
-
-
Uy, H.L.1
Dallas, M.2
Calland, J.W.3
Boyce, B.F.4
Mundy, G.R.5
-
28
-
-
16344362279
-
Growth inhibition of multiple myeloma cells by a novel IkappaB kinase inhibitor
-
Sanda T, Iida S, Ogura H, Asamitsu K, Murata T, et al. (2005) Growth inhibition of multiple myeloma cells by a novel IkappaB kinase inhibitor. Clinical cancer research: an official journal of the American Association for Cancer Research 11: 1974-1982.
-
(2005)
Clinical Cancer Research: An Official Journal of the American Association for Cancer Research
, vol.11
, pp. 1974-1982
-
-
Sanda, T.1
Iida, S.2
Ogura, H.3
Asamitsu, K.4
Murata, T.5
-
29
-
-
31944436270
-
Inhibition of human immunodeficiency virus type 1 replication in latently infected cells by a novel IkappaB kinase inhibitor
-
Victoriano AF, Asamitsu K, Hibi Y, Imai K, Barzaga NG, et al. (2006) Inhibition of human immunodeficiency virus type 1 replication in latently infected cells by a novel IkappaB kinase inhibitor. Antimicrobial agents and chemotherapy 50: 547-555.
-
(2006)
Antimicrobial Agents and Chemotherapy
, vol.50
, pp. 547-555
-
-
Victoriano, A.F.1
Asamitsu, K.2
Hibi, Y.3
Imai, K.4
Barzaga, N.G.5
|